Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
02 March 2018
Pharmanutra: highly successful first edition of the convention dedicated to international partners
22 February 2018
PHARMANUTRA: 2017 PRELIMINARY RESULTS DOUBLE-DIGIT REVENUE AND MARGIN GROWTH
01 February 2018
PHARMANUTRA: IN ARRIVO 4 NUOVI PRODOTTI SUL MERCATO
27 January 2018
Calendario degli eventi societari
18 October 2017
COMMUNICATION OF CHANGING SOCIAL CAPITAL
30 September 2017
COMUNICATO STAMPA – CONVERSIONE DELLE PRICE ADJUSTMENT SHARE
30 September 2017
ESERCIZIO DEI WARRANT DI PHARMANUTRA S.P.A. PER IL PERIODO DAL 1 AL 29 SETTEMBRE 2017
18 September 2017
PHARMANUTRA S.P.A. APPROVA LA RELAZIONE SEMESTRALE AL 30 GIUGNO 2017
11 September 2017
PHARMANUTRA: CETILAR® DIVENTA MAIN SPONSOR DEL PARMA CALCIO 1913
31 August 2017
ESERCIZIO DEI WARRANT DI PHARMANUTRA S.P.A. PER IL PERIODO DAL 1 AL 31 AGOSTO 2017
01 August 2017
VERIFICATA LA CONDIZIONE DI ACCELERAZIONE DEI WARRANT PHARMANUTRA S.P.A.
01 August 2017
Comunicazione di accelerazione WARRANT PHARMANUTRA S.P.A. IT0005274185
<
1
…
16
17
18
>